Frequently asked questions
In 2022, the market for compression therapy was estimated to be worth USD 3514.8 million.
The market for compression therapy is anticipated to increase at a CAGR of 5.80% from 2023 to 2030, reaching USD 5518.05 million in 2030.
Compression bandages are the most popular category of product type.
Gradient compression, by the compression level, is the notable segment.
During the projection period, the venous disorders category is anticipated to exhibit the highest CAGR.
The compression therapy market was ruled by North America.
The top players include Cardinal Health; Julius Zorn GmbH; Hartmann AG; Medi GmbH & Co.; SIGVARIS; BSN Medical GmbH; Arjo Huntleigh; 3M Health Care; Spectrum Healthcare; Bio Compression Systems, Inc.; Stryker; Gottfried Medical, and others.
Compression therapy is now more widely accepted among patients and healthcare professionals as a result of increased knowledge of its benefits for accelerating wound healing, minimizing edema, and treating chronic venous disorders. Superior treatment outcomes, as a result, have helped to maintain compression therapy’s favorable reputation. These are the significant factors that boost the growth of the global market.
The challenges limiting the growth of the compression therapy market are the research and development costs and the global supply chain disruptions.
Compression therapy integration potential has been made possible by the COVID-19 pandemic, which has pushed the development of telemedicine and remote monitoring. Moreover, compression therapy patients from outside can be drawn to areas with a strong medical tourism industry, expanding the market’s reach internationally.